Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

DPH 846.50 +0.50 (0.06%)
price chart
Dechra Pharmaceuticals plc Price Target Increased to GBX 950 by Analysts at ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) had its price objective hosited by Jefferies Group from GBX 871 ($13.07) to GBX 950 ($14.26) in a report released on Tuesday.
Jefferies Group Boosts Dechra Pharmaceuticals plc Price Target to GBX 950 ...  Ticker Report
Equities Research Analysts' Price Target Changes for January, 27th (ADC ...  Mideast Time
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
Back in February last year I penned an article titled David & Goliath: AstraZeneca versus Hikma Pharmaceuticals, which compared the prospects of the two firms and suggested that looking down the food chain in the pharmaceutical sector could produce an ...
Investment Analysts' Weekly Ratings Changes for Dechra Pharmaceuticals ...  The Legacy
Dechra Pharmaceuticals plc Given New GBX 950 Price Target at Panmure Gordon  Dakota Financial News
Research Analysts' Recent Ratings Updates for Dechra Pharmaceuticals plc ...
1/14/2015 - Dechra Pharmaceuticals plc had its �buy� rating reaffirmed by analysts at FinnCap. They now have a GBX 940 ($14.23) price target on the stock, up previously from GBX 840 ($12.71).
Dechra Pharmaceuticals plc Stock Rating Reaffirmed by FinnCap
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH)'s stock had its �buy� rating reaffirmed by stock analysts at FinnCap in a report issued on Wednesday.
Panmure Gordon Raises Dechra Pharmaceuticals plc Price Target to GBX 950  WKRB News
Dechra Pharmaceuticals plc Receives Consensus Rating of "Buy" from ...  sleekmoney
Numis Securities Ltd Reaffirms Add Rating for Dechra Pharmaceuticals plc (DPH)
Dechra Pharmaceuticals plc logo Numis Securities Ltd reissued their add rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research report released on Wednesday morning. Numis Securities Ltd currently has a GBX 862 ($13.01) price ...
Dechra Pharmaceuticals plc Price Target Raised to GBX 960  sleekmoney
Oriel Securities Ltd Lowers Dechra Pharmaceuticals plc to Hold  Ticker Report
Dechra Pharmaceuticals plc Now Covered by Analysts at Numis Securities Ltd ...
Dechra Pharmaceuticals plc logo Numis Securities Ltd began coverage on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research note issued to investors on Wednesday.
Related articles »  
Dechra Pharmaceuticals plc Receives Consensus Recommendation of "Buy ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been given a consensus recommendation of �Buy� by the seven analysts that are covering the stock, AnalystRatingsNetwork reports.
Related articles »  
Dechra Pharmaceuticals plc's �Add� Rating Reiterated at Oriel Securities Ltd (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH)'s stock had its �add� rating reiterated by equities researchers at Oriel Securities Ltd in a research report issued on Monday.
Dechra Pharmaceuticals plc Stock Rating Reaffirmed by Oriel Securities Ltd (DPH)  Mideast Time
Related articles »  
Dechra Pharmaceuticals plc's "Hold" Rating Reiterated at N+1 Singer (DPH)
Receive News & Ratings for Dechra Pharmaceuticals plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals plc and related companies with Analyst Ratings Network's ...
Related articles »  
Dechra Pharmaceuticals plc to Issue Dividend of GBX 10.65 on November 21st ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) announced a dividend on Monday, September 8th, Analyst Ratings Network reports.
Related articles »